PRECIGEN Investors

Press & Events

World Vaccine & Immunotherapy Congress

Dec 05, 2019 at 12:10 PM PST

Helen Sabzevari, PhD, President of Precigen, will present the keynote “Unleashing the potential of gene therapy using the non-viral UltraCAR-T platform for hematological and solid tumors.”

Location

San Francisco, CA